This dual peptide blend pairs CJC-1295 (No DAC), also known as Modified GRF (1-29), with Ipamorelin two growth hormone secretagogues that act on complementary pathways in a single lyophilised vial containing 5mg of each
Psychiatry 64 , 11231131 (2007)
Patients should be advised that "GLP-1 probiotic" marketing claims are not FDA-evaluated and may be misleading
The STEP 1 trial for semaglutide showed average weight reduction of 13.6 kg, with 62% coming from fat mass and 38% from lean body mass
Less time in the stomach means less exposure to its harsh environment and a higher probability that the full, intact dose of the peptide will be released exactly where it needs to bein the more neutral environment of the duodenum and small intestine, where absorption takes place
Be sure to check out the above recommended articles to learn more